NEWS & EVENTS

Sleep Disorders Research Advisory Board (SDRAB) Meeting – December 5, 2024

Fully Virtual
Registration Required

Description

The purpose of this meeting is to update the Advisory Board and public stakeholders on the progress of sleep and circadian research activities across NIH, and the activities of Federal stakeholders and interested organizations. The tentative meeting agenda appears below.

Tentative Agenda

Call to Order 11:00 AM (Eastern)
Leadership Lens

NIH Office of Dietary Supplements (ODS) 
Stefan Pasiakos, Ph.D.  
Director, ODS, NIH

Scientific Focus Presentation  

Circadian Biology and Non-Pharmacological Therapies 
Helen Burgess, Ph.D. 
Professor, Department of Psychiatry
Co-Director, Sleep and Circadian Research Laboratory
University of Michigan

Report from the National Center on Sleep Disorders Research (NCSDR)

Marishka Brown, Ph.D.
Director, NCSDR, NHLBI, NIH

Center for Scientific Review (CSR) Presentation

R-01 Simplified Process 
Brittany Mason-Mah, Ph.D. 
Scientific Review Officer
Mechanisms of Emotion, Stress and Health (MESH), CSR
Valerie Durrant, Ph.D.
Director 
Division of AIDS, Behavioral and Population Science, CSR

Update from Stakeholder Group

Society for Biological Rhythms (SRBR) 
John Hogenesch, Ph.D.
Professor of Pediatrics, Cincinnati Children’s Hospital Medical Center
President, SRBR

Federal Stakeholder Update 

Department of Defense 
Michael Goodson, Ph.D.
Research Biologist
U.S. Air Force Research Laboratory
Jason Soares
U.S. Army DEVCOM Soldier Center

NIH-wide Sleep Research Coordinating Committee (SRCC) Presentation   

National Institute of General Medical Sciences (NIGMS) 
Michael Sesma, Ph.D
Health Scientist Administrator, NIGMS
Lameese Akacem, Ph.D. 
Program Officer, NIGMS

Advisory Board Discussion – Part 1 

Lead by Esra Tasali, M.D.

NIH-wide Programmatic Updates

Researching COVID to Enhance Recovery (RECOVER)
Susan Redline, M.D., M.P.H. 
Professor of Sleep Medicine, Brigham and Women’s Hospital
Professor of Epidemiology, Harvard University School of Public Health

Public Comment
Advisory Board Discussion – Part 2 

Lead by Esra Tasali, M.D.